Richard Stefanacci

Dr. Richard Stefanacci currently serves as the Chief Medical Officer at TauRx Therapeutics Ltd., overseeing regulatory approval, market access, and utilization of the TauRx Alzheimer's treatment, HMTM. Additionally, Dr. Richard holds various roles at Thomas Jefferson University, Go4theGoal Foundation, Mercy LIFE, EVERSANA, AtlantiCare, and the University of the Sciences in Philadelphia. Dr. Stefanacci has a Master's Degree in Geriatric Healthcare, an MBA in Health/Health Care Administration/Management, and an MD in Osteopathic Medicine/Osteopathy. Dr. Richard also holds a Bachelor's Degree in Economics/Biology and has extensive experience in the healthcare industry.